Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, Fábio Camargo Abdalla, Hagai Abeliovich, +1232

Autophagy

MitophagyParticular Autophagy AssaysImmunologyCytoskeletonMultiple Assays +17

Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy

Zheqiong Tan, Lanbo Xiao, Min Tang, +18

Theranostics

Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning

Jie-Yi Shi, Xiaodong Wang, Guangyu Ding, +18

Gut

Molecular Basis of Immortalization of Human Mesenchymal Stem Cells by Combination of p53 Knockdown and Human Telomerase Reverse Transcriptase Overexpression

Tongming Liu, Wei Ming Ng, Hwee San Tan, +7

Stem Cells and Development

Regenerative MedicineMesenchymal Stem CellsLifespan ExtensionDevelopmental BiologyMedicine +12

Dissecting Intra-Tumoral Changes Following Immune Checkpoint Blockades in Intrahepatic Cholangiocarcinoma via Single-Cell Analysis

Bao‐Ye Sun, Cheng Zhou, Ruo‐Yu Guan, +8

Frontiers in Immunology

Anlotinib potentiates anti‐PD1 immunotherapy via transferrin receptor‐dependent CD8⁺ T‐cell infiltration in hepatocellular carcinoma

Fei Song, Bo Hu, Xiao‐Liang Liang, +11

Clinical and Translational Medicine

Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma

Jia‐Cheng Lu, Lei‐Lei Wu, Yining Sun, +27

Nature Communications

HepatologyMacro Cd5l+MedicineLiver PhysiologyHepatobiliary Tumor +9

PD-L1 interacts with Frizzled 6 to activate β-catenin and form a positive feedback loop to promote cancer stem cell expansion

Lingchen Fu, Jia Fan, Sudipa Maity, +3

Oncogene

Tumor BiologyPd-l1 InteractsSignaling PathwayMedicineStem Cells +10

Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cells

Weiwei Xu, Mirza Muhammad Fahd Qadir, Daniela Nasteska, +31

Cell Reports

Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study

Yong Yi, Bao‐Ye Sun, Jialei Weng, +10

Frontiers in Oncology